Human marrow stromal cells activate monocytes to secrete osteopontin, which down-regulates Notch1 gene expression in CD34+ cells

Blood

Volumn 103, Issue 12, 2004, Pages 4496-4502

  Iwata, Mineo ^a   Awaya, Norihiro ^a   Graf, Lynn ^a   Kahl, Christoph ^a   Torok Storb, Beverly ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; OSTEOPONTIN;

ARTICLE; CELL ACTIVATION; COCULTURE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MICROENVIRONMENT; MONOCYTE; NORTHERN BLOTTING; NOTCH1 GENE; NUCLEOTIDE SEQUENCE; OSTEOPONTIN GENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION;

EID: 2942584861     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0256     Document Type: Article

References (48)

1. Awaya N, Rupert K, Bryant E, Torok-Storb B. Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Exp Hematol. 2002;30:937-942.
2. Bagby GC Jr. Interleukin-1 and hematopoiesis. Blood Rev. 1989;3:152-161.
3. Horii Y, Muraguchi A, Suematsu S, et al. Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol. 1988;141:1529-1535.
4. Cannistra SA, Rambaldi A, Spriggs DR, Herrmann F, Griffin JD. Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes. J Clin Invest. 1987;79:1720-1728.
5. Mielcarek M, Roecklein BA, Torok-Storb B. CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood. 1996;87:574-580.
6. Rameshwar P, Denny TN, Stein D, Gascon P. Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-beta. J Immunol. 1994;153:2819-2830.
7. Shimokado K, Raines EW, Madtes DK, Barrett TB, Benditt EP, Ross R. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell. 1985;43:277-286.
8. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci U S A. 1981;78:5339-5343.
9. Antoniades HN, Stathakos D, Scher CD. Isolation of a cationic polypeptide from human serum that stimulates proliferation of 3T3 cells. Proc Natl Acad Sci U S A. 1975;72:2635-2639.
10. Roberts AB, Spom MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986;83:4167-4171.
11. Thiemann FT, Moore KA, Smogorzewska EM, Lemischka IR, Crooks GM. The mudne stromal cell line AFT024 acts specifically on human CD34+CD38-progenitors to maintain primitive function and immunophenotype in vitro. Exp Hematol. 1998;26:612-619.
12. Tsai S, Emerson SG, Sieff CA, Nathan DG. Isolation of a human stromal cell strain secreting hemopoietic growth factors. J Cell Physiol. 1986;127:137-145.
13. Novotny JR, Duehrsen U, Welch K, Layton JE, Cebon JS, Boyd AW. Cloned stromal cell lines derived from human Whitlock/Witte-type long-term bone marrow cultures. Exp Hematol. 1990;18:775-784.
14. Slack JL, Nemunaitis J, Andrews DF, Singer JW. Regulation of cytokine and growth factor gene expression in human bone marrow stromal cells transformed with simian virus 40. Blood. 1990;75:2319-2327.
15. Thalmeier K, Meissner P, Reisbach G, Falk M, Brechtel A, Dormer P. Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity. Blood. 1994;83:1799-1807.
16. Roecklein BA, Torok-Storb B. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood. 1995;85:997-1005.
17. Li L, Milner LA, Deng Y, et al. The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity. 1998;8:43-55.
18. Hashimoto S, Nagai S, Sese J, et al. Gene expression profile in human leukocytes. Blood. 2003;101:3509-3513.
19. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood. 2002;99:2369-2378.
20. Ohishi K, Varnum-Finney B, Bernstein ID. The notch pathway: modulation of cell fate decisions in hematopoiesis [review]. Int J Hematol. 2002;75:449-459.
21. Le Beau MM, Epstein ND, O'Brien SJ, et al. The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q. Proc Natl Acad Sci U S A. 1987;84:5913-5917.
22. McNiece I, Briddell R, Stoney G, et al. Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery. J Hematother. 1997;6:5-11.
23. Derisi JL, Iyer VR, Brown PO. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science. 1997;278:680-686.
24. Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002;30: e15.
25. Baldi P, Long AD. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics. 2001;17:509-519.
26. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1982.
27. Iwata M, Graf L, Awaya N, Torok-Storb B. Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein. Blood. 2002;100:1318-1325.
28. O'Regan AW, Nau GJ, Chupp GL, Berman JS. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks [review]. Immunol Today. 2000;21:475-478.
29. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival [review]. J Clin Invest. 2001;107:1055-1061.
30. Mielcarek M, Reems J, Torok-Storb B. Extrinsic control of stem cell fate: practical considerations. Stem Cells. 1997;15:229-236.
31. Atkins K, Berry JE, Zhang WZ, et al. Coordinate expression of OPN and associated receptors during monocyte/macrophage differentiation of HL-60 cells. J Cell Physiol. 1998;175:229-237.
32. 1 integrin. J Cell Sci. 1998;111(pt 9):1165-1174.
33. Cichy J, Pure E. The liberation of CD44 [review]. J Cell Biol. 2003;161:839-843.
34. Katagiri YU, Sleeman J, Fujii H, et al. CD44 variants but not CD44s cooperate with β1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 1999;59:219-226.
35. Druker BJ, Mamon HJ, Roberts TM. Oncogenes, growth factors, and signal transduction [review]. N Engl J Med. 1989;321:1383-1391.
36. Patarca R, Saavedra RA, Cantor H. Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene [review]. Crit Rev Immunol. 1993;13:225-246.
37. Wilson HL, O'Neill HC. Identification of differentially expressed genes representing dendritic cell precursors and their progeny. Blood. 2003;102:1661-1669.
38. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, Nutman TB. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood. 2003;102:672-681.
39. Martin PJ, Najfeld V, Fialkow PJ. B-lymphoid cell involvement in chronic myelogenous leukemia: implications for the pathogenesis of the disease. Cancer Genet Cytogenet. 1982;6:359-368.
40. Ashkar S, Weber GF, Panoutsakopoulou V, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000;287:860-864.
41. Jansson M, Panoutsakopoulou V, Baker J, Klein L, Cantor H. Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J Immunol. 2002;168:2096-2099.
42. Maillard I, He Y, Pear WS. From the yolk sac to the spleen: new roles for Notch in regulating hematopoiesis. Immunity. 2003;18:587-589.
43. Izon DJ, Punt JA, Pear WS. Deciphering the role of Notch signaling in lymphopoiesis [review]. Curr Opin Immunol. 2002;14:192-199.
44. Milner LA, Bigas A. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation [review]. Blood. 1999;93:2431-2448.
45. Kumano K, Chiba S, Kunisato A, et al. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity. 2003;18:699-711.
46. Kunisato A, Chiba S, Nakagami-Yamaguchi E, et al. HES-1 preserves purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo. Blood. 2003;101:1777-1783.
47. Varnum-Finney B, Xu L, Brashem-Stein C, et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch 1 signaling. Nat Med. 2000;6:1278-1281.
48. Han H, Tanigaki K, Yamamoto N, et al. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int Immunol. 2002;14:637-645.